Histrelin Subcutaneous and Oxybutynin Extended-Release Tablets
Determining the interaction of Histrelin Subcutaneous and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin Subcutaneous-Oxybutynin Gel
- Histrelin Subcutaneous-Oxybutynin Oral Solution
- Histrelin Subcutaneous-Oxybutynin Syrup
- Histrelin Subcutaneous-Oxybutynin Tablets
- Histrelin Subcutaneous-Oxybutynin transdermal
- Histrelin Subcutaneous-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Histuss PD
- Oxybutynin Extended-Release Tablets-Hivid
- Oxybutynin Extended-Release Tablets-Hizentra
- Oxybutynin Extended-Release Tablets-HMS
- Oxybutynin Extended-Release Tablets-Hold
- Oxybutynin Extended-Release Tablets-Homatropaire